chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Potential side effects from the vaccine; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION COMPLICATION (Potential side effects from the vaccine) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Potential side effects from the vaccine). At the time of the report, VACCINATION COMPLICATION (Potential side effects from the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient's medical history was not provided.  No relevant concomitant medications were reported. No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site pain
Clinical narrative: Lump (swelling); Injection site pain (arm pain); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Lump (swelling)) and VACCINATION SITE PAIN (Injection site pain (arm pain)) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site pain (arm pain)). On 27-Mar-2021, the patient experienced VACCINATION SITE MASS (Lump (swelling)). At the time of the report, VACCINATION SITE MASS (Lump (swelling)) and VACCINATION SITE PAIN (Injection site pain (arm pain)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported. No treatment information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 22-Mar-2021, PAIN IN EXTREMITY (Sore arm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided. No relevant concomitant medications were reported. Treatment details also included arthritis cream.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Inappropriate schedule of vaccine administered; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 26-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 26-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug was provided.  No treatment information provided.   This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273, (Batch number: unknown) with no associated AEs.   Reporter did not allow further contact; Sender's Comments: This report refers to a case of Inappropriate Schedule Of Product Administration for mRNA-1273, (Batch number: unknown) with no associated AEs.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever of 100.7 deg F.; Terrible headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.7 deg F.) and HEADACHE (Terrible headache) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047*21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced PYREXIA (Fever of 100.7 deg F.) and HEADACHE (Terrible headache). At the time of the report, PYREXIA (Fever of 100.7 deg F.) and HEADACHE (Terrible headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, Pyrexia: 100.7 (High) fever of 100.7 deg F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's medical history was not provided.  No relevant concomitant medications were reported. The patient did not receive any treatment.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Nuchal rigidity, Vaccination site pain
Clinical narrative: lots of stiffness on the right arm; unable to move the neck towards left side; pain at left arm near shoulder at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (lots of stiffness on the right arm), NUCHAL RIGIDITY (unable to move the neck towards left side) and VACCINATION SITE PAIN (pain at left arm near shoulder at injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024B21A and 015M30A) for COVID-19 vaccination.     No medical history was reported by reporter.  Concomitant products included BENAZEPRIL for Blood pressure high, ASPIRIN [ACETYLSALICYLIC ACID], FOLIC ACID, VITAMINS NOS, LEVOTHYROXINE, DOXAZOSIN MESILATE (DOXAZOCIN), HYDROXYCHLOROQUINE, PREDNISONE and ADALIMUMAB (HUMIRA) for an unknown indication.   On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain at left arm near shoulder at injection site). On 28-Mar-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (lots of stiffness on the right arm) and NUCHAL RIGIDITY (unable to move the neck towards left side). At the time of the report, MUSCULOSKELETAL STIFFNESS (lots of stiffness on the right arm), NUCHAL RIGIDITY (unable to move the neck towards left side) and VACCINATION SITE PAIN (pain at left arm near shoulder at injection site) outcome was unknown.            concomitant medications included OTC  medications.  treatment information was not provided.   This case was linked to MOD-2021-258008 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow up received on 15 Jul 2021 contains non significant information
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Nausea, Pain, Vomiting
Clinical narrative: Generalized Aches/Pain; Hot Sensation; Nausea; Vomiting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Generalized Aches/Pain), FEELING HOT (Hot Sensation), NAUSEA (Nausea) and VOMITING (Vomiting) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022M2O and 018B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced PAIN (Generalized Aches/Pain), FEELING HOT (Hot Sensation), NAUSEA (Nausea) and VOMITING (Vomiting). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Generalized Aches/Pain), FEELING HOT (Hot Sensation), NAUSEA (Nausea) and VOMITING (Vomiting) outcome was unknown.            No relevant concomitant medications were reported. Action taken with mRNA-1273 in response to the events was not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Some of the dose dripped on the arm; Some of the dose dripped on the arm; A spontaneous report was received from a consumer, concerning herself, a 68-year-old, female patient, who received Moderna's COVD-19 vaccine (mRNA-1273) and reported  that some of the dose dripped on her arm(underdose, device connection issue).  The patient's medical history included Allergic to lisinopril. Concomitant product use was not provided by the reporter.  On 24-Feb-2021, prior to the onset of events, the patient received her first of the two planned vaccine doses of mRNA-1273 (batch number unknown) for COVID-19 infection prophylaxis.  On 27-Mar-2021, patient received the second of the two planned vaccine doses of mRNA-1273 (batch number 003B21A) via unknown route on her right arm for COVID-19 infection prophylaxis.   On the same day, she reported that some of the dose dripped on her right arm while the dose was administered. No treatment medication was reported.  Action taken with mRNA 1273 in response to the event was not applicable.  The outcome of the event, some of the dose dripped on her arm, was considered resolved.; Reporter's Comments: This report refers to a case of Underdose and Device connection issue, for mRNA-1273, lot #: 003B21A,  with no associated AEs.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: red spot a little itchy; quarter size red spot below injection site; injection arm a little sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red spot a little itchy), VACCINATION SITE PAIN (injection arm a little sore) and VACCINATION SITE ERYTHEMA (quarter size red spot below injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PAIN (injection arm a little sore). On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (red spot a little itchy) and VACCINATION SITE ERYTHEMA (quarter size red spot below injection site). On 18-Mar-2021, VACCINATION SITE PAIN (injection arm a little sore) had resolved. At the time of the report, VACCINATION SITE PRURITUS (red spot a little itchy) and VACCINATION SITE ERYTHEMA (quarter size red spot below injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Reporter's address was updated, Patient's demographic details (age) and route of administration of vaccine was added.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rashes on legs and thigh; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rashes on legs and thigh) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D NOS and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, the patient experienced RASH (Rashes on legs and thigh). The patient was treated with PARACETAMOL (TYLENOL) (oral) at an unspecified dose and frequency. At the time of the report, RASH (Rashes on legs and thigh) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: Itching Injection Site; Pink circle (3"-4") Injection Site; Swollen Injection Site; Pain on the Injection Site; Tenderness on the Injection Site Left Arm; Swelling on the Injection Site Left Arm; Right Arm hurt (Not Injected in this arm); This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Right Arm hurt (Not Injected in this arm)), VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Pink circle (3"-4") Injection Site), VACCINATION SITE SWELLING (Swelling on the Injection Site Left Arm) and VACCINATION SITE SWELLING (Swollen Injection Site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Right Arm hurt (Not Injected in this arm)). On 19-Mar-2021, the patient experienced VACCINATION SITE SWELLING (Swelling on the Injection Site Left Arm) and VACCINATION SITE PAIN (Tenderness on the Injection Site Left Arm). On 23-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Pink circle (3"-4") Injection Site), VACCINATION SITE SWELLING (Swollen Injection Site) and VACCINATION SITE PAIN (Pain on the Injection Site). On 17-Mar-2021, PAIN IN EXTREMITY (Right Arm hurt (Not Injected in this arm)) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching Injection Site), VACCINATION SITE RASH (Pink circle (3"-4") Injection Site), VACCINATION SITE SWELLING (Swelling on the Injection Site Left Arm), VACCINATION SITE SWELLING (Swollen Injection Site), VACCINATION SITE PAIN (Tenderness on the Injection Site Left Arm) and VACCINATION SITE PAIN (Pain on the Injection Site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Anti-Itch lotion.  No relevant concomitant medications were reported.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Arm Soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Arm Soreness) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced VACCINATION SITE PAIN (Arm Soreness). At the time of the report, VACCINATION SITE PAIN (Arm Soreness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was provided. No concomitants were reported.
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: something was leaking onto his arm from the syringe; concerned he did not receive full dose of the moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DEVICE CONNECTION ISSUE (something was leaking onto his arm from the syringe) and UNDERDOSE (concerned he did not receive full dose of the moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced DEVICE CONNECTION ISSUE (something was leaking onto his arm from the syringe) and UNDERDOSE (concerned he did not receive full dose of the moderna vaccine). On 25-Mar-2021, DEVICE CONNECTION ISSUE (something was leaking onto his arm from the syringe) and UNDERDOSE (concerned he did not receive full dose of the moderna vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Decreased appetite, Epistaxis, Erythema, Palpitations
Clinical narrative: Speedy racing heart; Bleeding nose; Red arm itchy; No appetite; Red arm itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (Speedy racing heart), EPISTAXIS (Bleeding nose), PRURITUS (Red arm itchy), DECREASED APPETITE (No appetite) and ERYTHEMA (Red arm itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PALPITATIONS (Speedy racing heart), EPISTAXIS (Bleeding nose), PRURITUS (Red arm itchy), DECREASED APPETITE (No appetite) and ERYTHEMA (Red arm itchy). At the time of the report, PALPITATIONS (Speedy racing heart), EPISTAXIS (Bleeding nose), PRURITUS (Red arm itchy), DECREASED APPETITE (No appetite) and ERYTHEMA (Red arm itchy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Blood pressure measurement: high mmHg (High) Greater than 200.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were specified. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Speedy racing heart; Bleeding nose; Red arm itchy; No appetite; Red arm itchy; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (Speedy racing heart), EPISTAXIS (Bleeding nose), PRURITUS (Red arm itchy), DECREASED APPETITE (No appetite) and ERYTHEMA (Red arm itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced PALPITATIONS (Speedy racing heart), EPISTAXIS (Bleeding nose), PRURITUS (Red arm itchy), DECREASED APPETITE (No appetite) and ERYTHEMA (Red arm itchy). At the time of the report, PALPITATIONS (Speedy racing heart), EPISTAXIS (Bleeding nose), PRURITUS (Red arm itchy), DECREASED APPETITE (No appetite) and ERYTHEMA (Red arm itchy) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Blood pressure measurement: high mmHg (High) Greater than 200.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were specified. No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site rash
Clinical narrative: itchy; Red; Rash; Swollen; Sore/Tender; Warm to touch; Hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Hard), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE RASH (Rash) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Hard), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE RASH (Rash), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Sore/Tender). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Hard), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE RASH (Rash), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Sore/Tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: itchy; Red; Rash; Swollen; Sore/Tender; Warm to touch; Hard; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Hard), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (Red) and VACCINATION SITE RASH (Rash) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Hard), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE RASH (Rash), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Sore/Tender). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (itchy). At the time of the report, VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE INDURATION (Hard), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE ERYTHEMA (Red), VACCINATION SITE RASH (Rash), VACCINATION SITE SWELLING (Swollen) and VACCINATION SITE PAIN (Sore/Tender) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.  No treatment information was provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Dizziness, Vaccination site pain
Clinical narrative: I feel very weak and light headed; I feel very weak and light headed; Arm is Sore; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (I feel very weak and light headed), DIZZINESS (I feel very weak and light headed) and VACCINATION SITE PAIN (Arm is Sore) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced ASTHENIA (I feel very weak and light headed), DIZZINESS (I feel very weak and light headed) and VACCINATION SITE PAIN (Arm is Sore). At the time of the report, ASTHENIA (I feel very weak and light headed), DIZZINESS (I feel very weak and light headed) and VACCINATION SITE PAIN (Arm is Sore) outcome was unknown.            No concomitant was provided. No treatment information was provided.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Cough, Exposure to SARS-CoV-2, Feeling abnormal
Clinical narrative: Total lack of energy after 1st dose; Slight cough after 1st dose; Shivering after 1st dose; Feeling horrible since 1st dose; Feels like he has COVID-19 again after 1st dose, exposed to COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling horrible since 1st dose), ASTHENIA (Total lack of energy after 1st dose), COUGH (Slight cough after 1st dose), EXPOSURE TO SARS-COV-2 (Feels like he has COVID-19 again after 1st dose, exposed to COVID-19) and CHILLS (Shivering after 1st dose) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19 on 01-Oct-2020.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced EXPOSURE TO SARS-COV-2 (Feels like he has COVID-19 again after 1st dose, exposed to COVID-19). On 24-Mar-2021, the patient experienced FEELING ABNORMAL (Feeling horrible since 1st dose). On an unknown date, the patient experienced ASTHENIA (Total lack of energy after 1st dose), COUGH (Slight cough after 1st dose) and CHILLS (Shivering after 1st dose). At the time of the report, FEELING ABNORMAL (Feeling horrible since 1st dose), ASTHENIA (Total lack of energy after 1st dose), COUGH (Slight cough after 1st dose), EXPOSURE TO SARS-COV-2 (Feels like he has COVID-19 again after 1st dose, exposed to COVID-19) and CHILLS (Shivering after 1st dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication were reported. Treatment medication was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Welts on her legs and arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Welts on her legs and arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L2UA) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Welts on her legs and arm). The patient was treated with LORATADINE (CLARITIN [LORATADINE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (Welts on her legs and arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant information was provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Glossodynia, Inflammation, Pain in extremity, Peripheral swelling, Rash
Clinical narrative: tongue is painful; bumps are inflamed; splotchy; red spots on the injection iste; arm pain; swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), PERIPHERAL SWELLING (swelling), GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed) and RASH (splotchy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain) and PERIPHERAL SWELLING (swelling). On 25-Mar-2021, the patient experienced GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed), RASH (splotchy) and VACCINATION SITE ERYTHEMA (red spots on the injection iste). At the time of the report, PAIN IN EXTREMITY (arm pain), PERIPHERAL SWELLING (swelling), GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed), RASH (splotchy) and VACCINATION SITE ERYTHEMA (red spots on the injection iste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Tylenol XR.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: tongue is painful; bumps are inflamed; splotchy; red spots on the injection iste; arm pain; swelling; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm pain), PERIPHERAL SWELLING (swelling), GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed) and RASH (splotchy) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain) and PERIPHERAL SWELLING (swelling). On 25-Mar-2021, the patient experienced GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed), RASH (splotchy) and VACCINATION SITE ERYTHEMA (red spots on the injection iste). At the time of the report, PAIN IN EXTREMITY (arm pain), PERIPHERAL SWELLING (swelling), GLOSSODYNIA (tongue is painful), INFLAMMATION (bumps are inflamed), RASH (splotchy) and VACCINATION SITE ERYTHEMA (red spots on the injection iste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details included Tylenol XR.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: numbness over both sides of the face; tingling over both sides of the face; tingling on the left side of the body; numbness on the left side of the body/numbness over the right side of the body; tingling over the right side of the body/tingling over both sides of the face; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling on the left side of the body), HYPOAESTHESIA (numbness on the left side of the body/numbness over the right side of the body), PARAESTHESIA (tingling over the right side of the body/tingling over both sides of the face), HYPOAESTHESIA (numbness over both sides of the face) and PARAESTHESIA (tingling over both sides of the face) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 008B21A) for COVID-19 vaccination.     No Medical History Information was reported.  Concomitant products included METFORMIN, METOPROLOL TARTRATE, APIXABAN (ELIQUIS), CITALOPRAM, HYDROCHLOROTHIAZIDE, OLMESARTAN MEDOXOMIL (OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE KRKA), SITAGLIPTIN PHOSPHATE (JANUVIA [SITAGLIPTIN PHOSPHATE]), OMEPRAZOLE, ATORVASTATIN and FISH OIL for an unknown indication.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced PARAESTHESIA (tingling on the left side of the body), HYPOAESTHESIA (numbness on the left side of the body/numbness over the right side of the body) and PARAESTHESIA (tingling over the right side of the body/tingling over both sides of the face). On 25-Mar-2021, the patient experienced HYPOAESTHESIA (numbness over both sides of the face) and PARAESTHESIA (tingling over both sides of the face). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (tingling on the left side of the body), HYPOAESTHESIA (numbness on the left side of the body/numbness over the right side of the body), PARAESTHESIA (tingling over the right side of the body/tingling over both sides of the face), HYPOAESTHESIA (numbness over both sides of the face) and PARAESTHESIA (tingling over both sides of the face) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications included Olmesartan-medox HCTZ.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Dyspnoea, Hyperhidrosis, Hypoaesthesia
Clinical narrative: uneasiness; dizziness; difficulty breathing; numb hands; cold sweats; shaking; chest pain; hands turned blue; vision was blurry; This spontaneous case was reported by a pharmacist and describes the occurrence of ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands) and HYPERHIDROSIS (cold sweats) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 08B212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE and BIOTIN for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands), HYPERHIDROSIS (cold sweats), TREMOR (shaking), CHEST PAIN (chest pain), SKIN DISCOLOURATION (hands turned blue) and VISION BLURRED (vision was blurry). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands), HYPERHIDROSIS (cold sweats), TREMOR (shaking), CHEST PAIN (chest pain), SKIN DISCOLOURATION (hands turned blue) and VISION BLURRED (vision was blurry) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Skin discolouration, Tremor, Vision blurred
Clinical narrative: uneasiness; dizziness; difficulty breathing; numb hands; cold sweats; shaking; chest pain; hands turned blue; vision was blurry; This spontaneous case was reported by a pharmacist and describes the occurrence of ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands) and HYPERHIDROSIS (cold sweats) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 08B212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE and BIOTIN for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands), HYPERHIDROSIS (cold sweats), TREMOR (shaking), CHEST PAIN (chest pain), SKIN DISCOLOURATION (hands turned blue) and VISION BLURRED (vision was blurry). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, ILLNESS (uneasiness), DIZZINESS (dizziness), DYSPNOEA (difficulty breathing), HYPOAESTHESIA (numb hands), HYPERHIDROSIS (cold sweats), TREMOR (shaking), CHEST PAIN (chest pain), SKIN DISCOLOURATION (hands turned blue) and VISION BLURRED (vision was blurry) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: Red rash at injection site; Swelling (puffed-up) at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE SWELLING (Swelling (puffed-up) at injection site) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE SWELLING (Swelling (puffed-up) at injection site). At the time of the report, VACCINATION SITE RASH (Red rash at injection site) and VACCINATION SITE SWELLING (Swelling (puffed-up) at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications not included. Patient treatment information was not provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Lymphadenopathy, Sinus disorder, Sinus headache
Clinical narrative: enlargement of lymph nodes on the left neck; Slight headache; sinus drainage; morning stuffiness; enlargement of lymph nodes on the right neck; This spontaneous case was reported by a consumer and describes the occurrence of SINUS DISORDER (sinus drainage), DYSPNOEA (morning stuffiness), LYMPHADENOPATHY (enlargement of lymph nodes on the right neck), LYMPHADENOPATHY (enlargement of lymph nodes on the left neck) and SINUS HEADACHE (Slight headache) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (seasonal allergies). Concomitant products included AZELASTINE for Allergy, ATORVASTATIN for Cholesterol, METOPROLOL for Hypertension, HYDROCHLOROTHIAZIDE for an unknown indication.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced SINUS DISORDER (sinus drainage), DYSPNOEA (morning stuffiness), LYMPHADENOPATHY (enlargement of lymph nodes on the right neck) and SINUS HEADACHE (Slight headache). On 28-Mar-2021, the patient experienced LYMPHADENOPATHY (enlargement of lymph nodes on the left neck). At the time of the report, SINUS DISORDER (sinus drainage), DYSPNOEA (morning stuffiness), LYMPHADENOPATHY (enlargement of lymph nodes on the right neck), LYMPHADENOPATHY (enlargement of lymph nodes on the left neck) and SINUS HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient took Z-pack (Azithromycin) as per prescribed by the Physician and Tylenol as treatment.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash macular, Rash pruritic, Skin irritation
Clinical narrative: blotches below his navel. It is itchy, irritating, and they are growing/area below navel started to irritate; Affected area is itchy; blotches below his navel. It is itchy, irritating, and they are growing/affected area is growing and spreading; blotches below navel/hair follicle growing two blemish or flat mole; This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (blotches below his navel. It is itchy, irritating, and they are growing/area below navel started to irritate), RASH MACULAR (blotches below navel/hair follicle growing two blemish or flat mole), RASH PRURITIC (Affected area is itchy) and RASH (blotches below his navel. It is itchy, irritating, and they are growing/affected area is growing and spreading) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 02L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced RASH MACULAR (blotches below navel/hair follicle growing two blemish or flat mole). On 26-Mar-2021, the patient experienced RASH PRURITIC (Affected area is itchy) and RASH (blotches below his navel. It is itchy, irritating, and they are growing/affected area is growing and spreading). On an unknown date, the patient experienced SKIN IRRITATION (blotches below his navel. It is itchy, irritating, and they are growing/area below navel started to irritate). At the time of the report, SKIN IRRITATION (blotches below his navel. It is itchy, irritating, and they are growing/area below navel started to irritate), RASH MACULAR (blotches below navel/hair follicle growing two blemish or flat mole), RASH PRURITIC (Affected area is itchy) and RASH (blotches below his navel. It is itchy, irritating, and they are growing/affected area is growing and spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    Most recent FOLLOW-UP information incorporated above includes: On 28-Mar-2021: Significant Follow-up received on 28-Mar-2021: Events updated and Events start date updated On 12-May-2021: Non-significant follow-up received on 12-May-2021: Reporter Contact details added
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Maternal exposure during pregnancy, Pain in extremity, Pregnancy test
Clinical narrative: extreme shoulder pain; loss of mobility in right arm; weakness; pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (extreme shoulder pain), PAIN IN EXTREMITY (loss of mobility in right arm), ASTHENIA (weakness) and MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 35-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 16-Dec-2020 and the estimated date of delivery was 22-Sep-2021. On 26-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). On an unknown date, the patient experienced ARTHRALGIA (extreme shoulder pain), PAIN IN EXTREMITY (loss of mobility in right arm) and ASTHENIA (weakness). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  On 26-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved. At the time of the report, ARTHRALGIA (extreme shoulder pain), PAIN IN EXTREMITY (loss of mobility in right arm) and ASTHENIA (weakness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Pregnancy test: positive (Positive) Positive. On 11-Mar-2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Genetic testing was performed on11 Mar 2021 which was normal.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan
Clinical narrative: extreme shoulder pain; loss of mobility in right arm; weakness; pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ARTHRALGIA (extreme shoulder pain), PAIN IN EXTREMITY (loss of mobility in right arm), ASTHENIA (weakness) and MATERNAL EXPOSURE DURING PREGNANCY (pregnant) in a 35-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 16-Dec-2020 and the estimated date of delivery was 22-Sep-2021. On 26-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant). On an unknown date, the patient experienced ARTHRALGIA (extreme shoulder pain), PAIN IN EXTREMITY (loss of mobility in right arm) and ASTHENIA (weakness). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fourteenth week of the pregnancy.  On 26-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant) had resolved. At the time of the report, ARTHRALGIA (extreme shoulder pain), PAIN IN EXTREMITY (loss of mobility in right arm) and ASTHENIA (weakness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Pregnancy test: positive (Positive) Positive. On 11-Mar-2021, Ultrasound scan: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Genetic testing was performed on11 Mar 2021 which was normal.